Intest Res.  2014 Apr;12(2):124-130. 10.5217/ir.2014.12.2.124.

Vaccination and Complementary and Alternative Medicine in Patients with Inflammatory Bowel Disease

Affiliations
  • 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. sjpark@yuhs.ac
  • 2Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.
  • 3Department of Internal Medicine, Ajou University College of Medicine, Suwon, Korea.

Abstract

BACKGROUND/AIMS
Vaccinations in patients with inflammatory bowel disease (IBD) are recommended to prevent infectious diseases. However, there are few reports of vaccination in IBD patients in Korea. The frequency of complementary and alternative medicine (CAM) use is high despite its uncertain effectiveness. This study aimed to identify the rates of vaccination and use of CAM in patients with IBD.
METHODS
A total of 219 patients attended an education session for IBD patients held at Severance Hospital on March 23, 2013. We conducted a survey on vaccination and CAM use in IBD patients; 120 patients completed the questionnaire.
RESULTS
The influenza vaccination rate was 44.2% and pneumococcal vaccination rate was 4.2%. Thirty-one (66%) patients were aware of the importance of vaccination. The vaccination rate was higher in patients who were aware of the importance of vaccination compared with that in patients who were unaware of the importance of vaccination (70.1% vs. 41.7%, P=0.004). The rate of CAM use was 30.0%. The most commonly used CAMs were oral products: vitamins (33.3%), red ginseng (25.0%), and probiotics (19.4%).
CONCLUSIONS
Awareness of the importance of vaccination and actual vaccination rates were low in IBD patients. Despite insufficient evidence on the effectiveness of CAMs in IBD patients, many patients used CAMs. We believe that repeated education and promotion of vaccination are important. Further large-scale studies to investigate the efficacy and safety of CAMs are warranted in patients with IBD.

Keyword

Inflammatory bowel disease; Vaccination; Complementary and alternative medicine; Awareness

MeSH Terms

Communicable Diseases
Complementary Therapies*
Education
Humans
Inflammatory Bowel Diseases*
Influenza, Human
Korea
Panax
Probiotics
Vaccination*
Vitamins
Surveys and Questionnaires
Vitamins

Figure

  • Fig. 1 Number of patients with IBD who received vaccinations and that of patients aware of the importance of vaccination.


Cited by  4 articles

SARS-CoV-2 Vaccination for Adult Patients with Inflammatory Bowel Disease: Expert Consensus Statements by KASID
Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seung-Jae Myung
Korean J Gastroenterol. 2021;78(2):117-128.    doi: 10.4166/kjg.2021.110.

Ideal Vaccination Strategy in Inflammatory Bowel Disease
Chang Kyun Lee
Korean J Gastroenterol. 2015;65(3):159-164.    doi: 10.4166/kjg.2015.65.3.159.

Complementary and alternative medicine in patients with inflammatory bowel disease: hype or evidence?
Jae Myung Cha
Intest Res. 2020;18(2):141-143.    doi: 10.5217/ir.2020.00022.

SARS-CoV-2 vaccination for adult patients with inflammatory bowel disease: expert consensus statement by KASID
Yoo Jin Lee, Seong-Eun Kim, Yong Eun Park, Ji Young Chang, Hyun Joo Song, Duk Hwan Kim, Young Joo Yang, Byung Chang Kim, Jae Gon Lee, Hee Chan Yang, Miyoung Choi, Seung-Jae Myung
Intest Res. 2022;20(2):171-183.    doi: 10.5217/ir.2021.00098.


Reference

1. Koning M, Ailabouni R, Gearry RB, Frampton CM, Barclay ML. Use and predictors of oral complementary and alternative medicine by patients with inflammatory bowel disease: a population-based, case-control study. Inflamm Bowel Dis. 2013; 19:767–778. PMID: 23429459.
Article
2. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008; 14:542–549. PMID: 17941073.
Article
3. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012; 142:46–54. PMID: 22001864.
Article
4. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asiapacific Crohn's and colitis epidemiology study. Gastroenterology. 2013; 145:158–165. PMID: 23583432.
Article
5. Ye BD, Yang SK, Shin SJ, et al. Guidelines for the management of Crohn's disease. Korean J Gastroenterol. 2012; 59:141–179. PMID: 22387837.
Article
6. Choi CH, Kim YH, Kim YS, et al. Guidelines for the management of ulcerative colitis. Korean J Gastroenterol. 2012; 59:118–140. PMID: 22387836.
Article
7. Gisbert JP, Chaparro M. Vaccination strategies in patients with IBD. Nat Rev Gastroenterol Hepatol. 2013; 10:277–285. PMID: 23419290.
Article
8. Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis. 2013; 7:107–112. PMID: 22440891.
Article
9. Stobaugh DJ, Deepak P, Ehrenpreis ED. Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample. Clin Exp Gastroenterol. 2013; 6:43–49. PMID: 23818801.
Article
10. Complementary, alternative, or integrative health: what's in a name?. National Center for Complementary and Alternative Medicine (NCCAM) [homepage on the Internet]. Maryland: NCCAM publication;updated 2013 May. cited 2008 October. Available from: http://nccam.nih.gov/health/whatiscam/.
11. Langhorst J, Anthonisen IB, Steder-Neukamm U, et al. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use. Complement Ther Med. 2007; 15:30–37. PMID: 17352969.
Article
12. Ng SC, Lam YT, Tsoi KK, Chan FK, Sung JJ, Wu JC. Systematic review: the efficacy of herbal therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2013; 38:854–863. PMID: 23981095.
Article
13. Campins M, Cossio Y, Martinez X, Borruel N. Vaccination of patients with inflammatory bowel disease. Practical recommendations. Rev Esp Enferm Dig. 2013; 105:93–102. PMID: 23659508.
Article
14. Wasan SK, Baker SE, Skolnik PR, Farraye FA. A practical guide to vaccinating the inflammatory bowel disease patient. Am J Gastroenterol. 2010; 105:1231–1238. PMID: 20104218.
Article
15. Kotton CN. Vaccines and inflammatory bowel disease. Dig Dis. 2010; 28:525–535. PMID: 20926882.
Article
16. Melmed GY. Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics. Inflamm Bowel Dis. 2009; 15:1410–1416. PMID: 19462435.
Article
17. Yun HS, Min YW, Chang DK, et al. Factors associated with vaccination among inflammatory bowel disease patients in Korea. Korean J Gastroenterol. 2013; 61:203–208. PMID: 23624734.
Article
18. Feuchtenberger M, Kleinert S, Schwab S, et al. Vaccination survey in patients with rheumatoid arthritis: a cross-sectional study. Rheumatol Int. 2012; 32:1533–1539. PMID: 21327432.
Article
19. Parker S, Chambers White L, Spangler C, et al. A quality improvement project significantly increased the vaccination rate for immunosuppressed patients with IBD. Inflamm Bowel Dis. 2013; 19:1809–1814. PMID: 23714677.
Article
20. Chae BJ, Song BJ, Kim SS, et al. Use of complementary and alternative medicine by gastric cancer patients. J Korean Surg Soc. 2007; 72:369–378.
Full Text Links
  • IR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr